Genelux Corporation (GNLX)
NASDAQ
Market Cap
$73.86M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
117 of 809
Rank in Industry
79 of 445
Largest Insider Buys in Sector
GNLX Stock Price History Chart
GNLX Stock Performance
About Genelux Corporation
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1 to treat hematologic and solid cancer. The company was incorporated in 2001 and is headquartered in Westlake Village, California.
Insider Activity of Genelux Corporation
Over the last 12 months, insiders at Genelux Corporation have bought $1.07M and sold $14.93M worth of Genelux Corporation stock.
On average, over the past 5 years, insiders at Genelux Corporation have bought $536,625 and sold $14.93M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Zindrick Thomas (President and CEO) — $800,000. Zak Lourie S. (Chief Financial Officer) — $125,000. Tyree James L (director) — $100,000.
The last purchase of 2,500 shares for transaction amount of $10,000 was made by Yu Yong (VP, Clinical Trial Operations) on 2024‑05‑29.
List of Insider Buy and Sell Transactions, Genelux Corporation
| 2024-05-29 | Thomas John | director | 2,500 0.0105% | $4.00 | $10,000 | -14.64% | ||
| 2024-05-29 | Zindrick Thomas | President and CEO | 200,000 0.8435% | $4.00 | $800,000 | -14.64% | ||
| 2024-05-29 | Zak Lourie S. | Chief Financial Officer | 31,250 0.1318% | $4.00 | $125,000 | -14.64% | ||
| 2024-05-29 | Smalling Ralph | Head of Regulatory | 1,250 0.0053% | $4.00 | $5,000 | -14.64% | ||
| 2024-05-29 | Smither John W | director | 6,250 0.0264% | $4.00 | $25,000 | -14.64% | ||
| 2024-05-29 | Mirabelli Mary | director | 8,000 0.0337% | $4.00 | $32,000 | -14.64% | ||
| 2024-05-29 | Ryder Sean | General Counsel | 10,000 0.0422% | $4.00 | $40,000 | -14.64% | ||
| 2024-05-29 | Tyree James L | director | 6,250 0.0264% | $4.00 | $25,000 | -14.64% | ||
| 2024-05-29 | Yu Yong | VP, Clinical Trial Operations | 2,500 0.0105% | $4.00 | $10,000 | -14.64% | ||
| 2024-05-15 | Sale | Szalay Aladar | 10 percent owner | 17,094 0.064% | $3.66 | $62,624 | -29.40% | |
| 2024-05-14 | Sale | Szalay Aladar | 10 percent owner | 15,426 0.0575% | $3.58 | $55,274 | -27.93% | |
| 2024-05-13 | Sale | Szalay Aladar | 10 percent owner | 3,446 0.0129% | $3.62 | $12,478 | -28.25% | |
| 2024-05-08 | Sale | Szalay Aladar | 10 percent owner | 13,919 0.0522% | $3.82 | $53,189 | -30.53% | |
| 2024-05-07 | Sale | Szalay Aladar | 10 percent owner | 6,025 0.0214% | $3.67 | $22,111 | -27.12% | |
| 2024-05-01 | Sale | Szalay Aladar | 10 percent owner | 33,061 0.1239% | $3.30 | $109,161 | -14.94% | |
| 2024-04-30 | Sale | Szalay Aladar | 10 percent owner | 20,535 0.0766% | $3.12 | $63,981 | -10.13% | |
| 2024-04-29 | Sale | Szalay Aladar | 10 percent owner | 6,403 0.0244% | $3.25 | $20,792 | -11.95% | |
| 2024-04-24 | Sale | Szalay Aladar | 10 percent owner | 8,064 0.0302% | $3.50 | $28,251 | -14.20% | |
| 2024-04-23 | Sale | Szalay Aladar | 10 percent owner | 22,000 0.0821% | $3.49 | $76,800 | -10.89% | |
| 2024-04-22 | Sale | Szalay Aladar | 10 percent owner | 14,331 0.0562% | $3.53 | $50,597 | -6.12% |
Insider Historical Profitability
279.92%
| Szalay Aladar | 10 percent owner | 1139821 5.145% | $2.15 | 0 | 31 | |
| Thomas John | director | 465960 1.7385% | $2.15 | 1 | 4 | |
| Zak Lourie S. | Chief Financial Officer | 31250 0.0923% | $2.15 | 1 | 0 | |
| Zindrick Thomas | President and CEO | 200000 0.055% | $2.15 | 1 | 1 | |
| Mirabelli Mary | director | 12460 0.0368% | $2.15 | 1 | 0 | |
| Smither John W | director | 13170 0.026% | $2.15 | 1 | 1 | |
| Cappello Joseph | VP, Pharmaceutical Development | 5735 0.0215% | $2.15 | 0 | 1 | |
| Tyree James L | director | 9710 0.013% | $2.15 | 1 | 1 | |
| Samuelson Doug | Chief Financial Officer | 2303 0.0086% | $2.15 | 0 | 1 | |
| Smalling Ralph | Head of Regulatory | 13315 0.0077% | $2.15 | 1 | 1 | |
| Jewett Caroline | Head of Quality | 1135 0.0043% | $2.15 | 0 | 1 | |
| Ryder Sean | General Counsel | 10572 0.0021% | $2.15 | 1 | 2 | |
| Yu Yong | VP, Clinical Trial Operations | 2500 0% | $2.15 | 1 | 13 | |
| Zhang Qian | Associate VP, Research | 200 0.0008% | $2.15 | 1 | 0 | +279.92% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| BlackRock | $7.92M | 3.64 | 1.23M | -5.03% | -$419,364.59 | <0.0001 | |
| Woodward Diversified Capital Llc | $6.98M | 3.21 | 1.09M | +0.34% | +$23,707.41 | 4.38 | |
| The Vanguard Group | $6.58M | 3.02 | 1.02M | +2.42% | +$155,734.60 | <0.0001 | |
| Geode Capital Management | $2.73M | 1.25 | 424,265 | +4.7% | +$122,537.98 | <0.0001 | |
| State Street | $2.54M | 1.17 | 395,015 | +4.66% | +$112,987.94 | <0.0001 | |
| Millennium Management LLC | $1.68M | 0.77 | 261,799 | +283.93% | +$1.24M | <0.01 | |
| Northern Trust | $1.04M | 0.48 | 162,485 | -0.97% | -$10,275.14 | <0.0001 | |
| Provident Wealth Management LLC | $1.01M | 0.46 | 157,137 | 0% | +$0 | 0.48 | |
| Charles Schwab | $980,633.00 | 0.45 | 152,509 | +1.94% | +$18,679.15 | <0.0001 | |
| Renaissance Technologies | $646,000.00 | 0.3 | 100,400 | New | +$646,000.00 | <0.01 | |
| Lincoln National Corporation | $392,326.00 | 0.18 | 61,015 | New | +$392,326.00 | 0.01 | |
| Morgan Stanley | $381,543.00 | 0.18 | 59,338 | -4.15% | -$16,531.51 | <0.0001 | |
| Nuveen | $371,590.00 | 0.17 | 57,790 | 0% | +$0 | <0.0001 | |
| AMG National Trust | $323,757.00 | 0.15 | 50,351 | +<0.01% | +$32.15 | 0.01 | |
| BNY Mellon | $312,533.00 | 0.14 | 48,606 | -9.72% | -$33,660.66 | <0.0001 | |
| Bank of America | $307,385.00 | 0.14 | 47,805 | +102.67% | +$155,721.16 | <0.0001 | |
| LINSCO PRIVATE LEDGER CORP | $295,536.00 | 0.14 | 45,962 | +6.29% | +$17,489.62 | <0.0001 | |
| Exchange Traded Concepts, LLC | $294,082.00 | 0.14 | 45,736 | +637.56% | +$254,209.64 | 0.01 | |
| Citadel Advisors LLC | $287,807.00 | 0.13 | 44,760 | New | +$287,807.00 | <0.0001 | |
| LifeSteps Financial | $284,907.00 | 0.13 | 44,309 | +26.57% | +$59,805.46 | 0.22 | |
| UBS | $283,666.00 | 0.13 | 44,116 | +117% | +$152,944.05 | <0.0001 | |
| D. E. Shaw & Co. | $230,914.00 | 0.11 | 35,912 | New | +$230,914.00 | <0.0001 | |
| Clearstead Advisors Llc | $108,192.00 | 0.09 | 29,970 | +19.88% | +$17,941.75 | 0.01 | |
| RhumbLine Advisers | $154,305.00 | 0.07 | 23,999 | +4% | +$5,940.99 | <0.0001 | |
| Kwb Wealth | $149,993.00 | 0.07 | 23,327 | 0% | +$0 | 0.02 | |
| Marshall Wace | $139,164.00 | 0.06 | 21,643 | New | +$139,164.00 | <0.0001 | |
| Xtx Topco Ltd | $122,569.00 | 0.06 | 19,062 | New | +$122,569.00 | 0.01 | |
| Sageview Advisory Group Llc | $313,572.00 | 0.06 | 18,788 | New | +$313,572.00 | <0.01 | |
| Plancorp, LLC | $117,219.00 | 0.05 | 18,230 | New | +$117,219.00 | 0.01 | |
| Axxcess Wealth Management Llc | $107,175.00 | 0.05 | 16,668 | 0% | +$0 | <0.01 | |
| Advisor Group Holdings Inc | $104,120.00 | 0.05 | 16,193 | +285.64% | +$77,120.69 | <0.0001 | |
| Apollon Wealth Management, LLC | $90,059.00 | 0.04 | 14,006 | 0% | +$0 | <0.01 | |
| Barclays | $86,000.00 | 0.04 | 13,428 | -47.27% | -$77,091.30 | <0.0001 | |
| Goldman Sachs | $84,786.00 | 0.04 | 13,186 | New | +$84,786.00 | <0.0001 | |
| Raymond James Financial Services Advisors Inc | $85,506.00 | 0.04 | 13,298 | -2.41% | -$2,115.47 | <0.0001 | |
| NovaPoint Capital | $82,664.00 | 0.04 | 12,856 | New | +$82,664.00 | 0.03 | |
| Occudo Quantitative Strategies Lp | $80,690.00 | 0.04 | 12,549 | New | +$80,690.00 | 0.01 | |
| Brown Brothers Harriman Co | $76,922.00 | 0.04 | 11,963 | -12.37% | -$10,860.26 | <0.01 | |
| Falcon Wealth Planning, Inc. | $77,160.00 | 0.04 | 12,000 | 0% | +$0 | 0.01 | |
| One Capital Management, LLC | $72,549.00 | 0.03 | 11,283 | 0% | +$0 | <0.01 | |
| Mariner Llc | $71,077.00 | 0.03 | 11,054 | New | +$71,077.00 | <0.0001 | |
| SteelPeak Wealth | $70,055.00 | 0.03 | 10,895 | 0% | +$0 | <0.01 | |
| Walleye Capital | $65,573.00 | 0.03 | 10,198 | New | +$65,573.00 | <0.0001 | |
| Ronald Blue Trust Inc | $63,683.00 | 0.03 | 9,904 | +7.22% | +$4,288.83 | <0.01 | |
| American International Group | $60,461.00 | 0.03 | 9,403 | +1.95% | +$1,157.39 | <0.0001 | |
| Wells Fargo | $60,950.00 | 0.03 | 9,479 | +11.71% | +$6,391.42 | <0.0001 | |
| JPMorgan Chase | $49,061.00 | 0.02 | 7,630 | -37.84% | -$29,860.98 | <0.0001 | |
| Deutsche Bank | $45,319.00 | 0.02 | 7,048 | +3.13% | +$1,376.03 | <0.0001 | |
| Whittier Trust Co Of Nevada Inc | $45,915.00 | 0.02 | 7,141 | 0% | +$0 | <0.01 | |
| New York State Common Retirement Fund | $41,000.00 | 0.02 | 6,441 | -0.31% | -$127.31 | <0.0001 |